Stockreport

Concert Pharmaceuticals initiates phase 1 program of CTP-692 for the treatment of schizophrenia [Seeking Alpha]

Concert Pharmaceuticals, Inc.  (CNCE) 
Last concert pharmaceuticals, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.concertpharma.com/investor-relations
PDF Concert Pharmaceuticals initiates phase 1 program of CTP-692 for the treatment of schizophrenia [Read more]